PC
Pathway Capital Management, LP
13F filer · CIK 0001037353Reported Aug 3, 2026
Net buyer this quarter
13F portfolio value$23.9MU.S. long equity reported on 13F
Positions44 new · 2 closed
Net flow last quarter+$15.5MBuys minus sells
Top 10 positions weight100.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 3, 20264 positions | |||||
| $12.8M | 53.56% | Not reported | Not reported | Q3 2024 | |
| $8.06M | 33.66% | 0.03% | Not reported | Q2 2023 | |
| $2.69M | 11.25% | 0.11% | Not reported | Q2 2025 | |
| $366K | 1.53% | 0.09% | New | Q2 2026 | |
| Q1 2026Reported May 1, 20262 positions | |||||
| $3.45M | 80.26% | 0.10% | New | Q1 2026 | |
| $848K | 19.74% | Not reported | -17.0% | Q4 2025 | |
| Q4 2025Reported Feb 4, 20265 positions | |||||
| $2.21M | 28.33% | 0.30% | Not reported | Q4 2023 | |
| $2.13M | 27.28% | 0.06% | Not reported | Q2 2025 | |
| $1.95M | 25.08% | 0.00% | New | Q4 2025 | |
| $1.2M | 15.34% | Not reported | New | Q4 2025 | |
| $310K | 3.97% | Not reported | Not reported | Q2 2021 | |
| Q3 2025Reported Nov 4, 20257 positions | |||||
| $6.77M | 33.26% | Not reported | Not reported | Q1 2024 | |
| AACLXArcellx, Inc. | $4.19M | 20.60% | 0.09% | Not reported | Q4 2022 |
| $4.17M | 20.51% | Not reported | +69.0% | Q2 2025 | |
| $3.24M | 15.95% | 0.05% | New | Q3 2025 | |
| $951K | 4.68% | 0.00% | Not reported | Q1 2021 | |
| $945K | 4.64% | Not reported | +62.7% | Q1 2024 | |
| NNEUENeuehealth, Inc. | $74.7K | 0.37% | 0.12% | Not reported | Q2 2024 |
Premium opens every quarter this fund has filed